Profund Advisors LLC Aclaris Therapeutics, Inc. Transaction History

Profund Advisors LLC

  • $2.59 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
BUY
$6.56 - $10.95 $85,922 - $143,423
13,098 New
13,098 $89,000
Q1 2023

May 11, 2023
BUY
$7.07 - $17.95 $98,053 - $248,948
13,869 New
13,869 $112,000
Q1 2019

May 15, 2019
SELL
$5.63 - $7.84 $82,822 - $115,334
-14,711 Closed
0 $0
Q4 2018

Feb 14, 2019
BUY
$6.3 - $15.4 $2,482 - $6,067
394 Added 2.75%
14,711 $109,000
Q3 2018

Nov 13, 2018
BUY
$14.38 - $20.89 $205,878 - $299,082
14,317 New
14,317 $208,000

Others Institutions Holding ACRS

# of Institutions
84
Shares Held
50.7M
Call Options Held
30.6K
Put Options Held
1K
View Full List

About Aclaris Therapeutics, Inc.

ACRS Quotes by TradingView
  • Ticker ACRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 66,671,800
  • Market Cap $253M
  • Description
  • Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...
More about ACRS
Track This Portfolio

Track Profund Advisors LLC Portfolio

Follow Profund Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email